{
    "eid": "2-s2.0-85135255252",
    "title": "Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Parasitology",
            "@code": "2405",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Microbiology",
            "@code": "2404",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Nasamon Wanlapakorn",
        "Nungruthai Suntronwong",
        "Sitthichai Kanokudom",
        "Suvichada Assawakosri",
        "Pornjarim Nilyanimit",
        "Ritthideach Yorsaeng",
        "Jira Chansaenroj",
        "Yong Poovorawan"
    ],
    "citedby-count": 4,
    "ref-count": 8,
    "ref-list": [
        "Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: real-world data",
        "Neutralizing activities against the omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination",
        "Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and omicron variants in prime immunized adults with two doses of the BBIBP-CorV vaccine",
        "Persistence of immunity against omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination",
        "Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination",
        "Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study",
        "Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and delta variants",
        "Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "126510119",
            "affilname": "FRS(T)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/126510119",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulabhorn Royal Academy",
        "Chulalongkorn University",
        "Ministry of Public Health",
        "National Research Council of Thailand",
        "Health Systems Research Institute"
    ]
}